Your browser doesn't support javascript.
loading
Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England.
Garjani, Afagh; Patel, Sameer; Bharkhada, Dhiren; Rashid, Waqar; Coles, Alasdair; Law, Graham R; Evangelou, Nikos.
Afiliação
  • Garjani A; Academic Neurology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; Mental Health and Clinical Neurosciences Academic Unit, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Patel S; Direct Commissioning, National Health Services Arden and Greater East Midlands Commissioning Support Unit, Leicester, United Kingdom.
  • Bharkhada D; National Health Services England and National Health Services Improvement Midlands Region, Derby, United Kingdom.
  • Rashid W; Neurology Department, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.
  • Coles A; Department of Clinical Neuroscience, University of Cambridge, Cambridge, United Kingdom.
  • Law GR; School of Health and Social Care, University of Lincoln, Lincoln, United Kingdom.
  • Evangelou N; Academic Neurology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; Mental Health and Clinical Neurosciences Academic Unit, School of Medicine, University of Nottingham, Nottingham, United Kingdom. Electronic address: nikos.evangelou@nottingham.ac.uk.
Mult Scler Relat Disord ; 57: 103458, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34896876
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Mult Scler Relat Disord Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Mult Scler Relat Disord Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido